Table 1

Clinical details of included studies

Study (year)nParticipantsDose*Long term follow up
*Doses were either 0.1 or 0.2 mg/kg and dosing interval 12 or 24 hours.
BW, Birth weight; GA, gestational age; MDI, mental developmental index; PDI, physical developmental index; CP, cerebral palsy.
Bada (1989)141BW <1500 g3 doses starting at 6 hoursNo
Bandstra (1988)199BW <1300 g3 doses starting at <12 hoursBetween 6 and 24 months: Bayley MDI and PDI
Couser (1996)93BW 600–1250 g6 doses starting <24 hoursNo
Domenico (1994)100BW <1250 g3 doses starting <12 hoursNo
Gutierrez (1987)59GA <34 weeks and BW <1751 g3 doses starting <24 hoursNo
Hanigan (1988)111BW <1500 g3 doses starting <12 hoursNo
Krueger (1987)32BW 750–1500 gSingle dose at 24 hoursNo
Mahony (1985)110BW 700–1300 g3 doses starting at 12–18 hoursNo
Ment (1985)48BW 600–1250 g5 doses starting at 6 hoursNo
Ment (1988)36BW 600–1250g3 doses starting at 6–12 hoursNo
Ment (1994a)61BW 600–1250 g3 doses starting at 6–12 hoursNo
Ment (1994b)431BW 600–1250 g3 doses starting at 6–12 hoursAt 36 and 54 months: Stanford Binet Intelligence Scale Peabody Picture Vocabulary Test (R), CP, blindness, deafness
Morales-Suarez (1994)80GA 28–36 weeks3 doses starting <12 hoursNo
Puckett (1985)32BW <1400 g3 doses starting at <24 hoursNo
Rennie (1986)50BW <1750 g3 doses starting <24 hoursNo
Supapannachart (1999)30BW <1250 g3 doses starting <24 hoursNo
Schmidt (2001)1202BW 500–999 g3 doses starting <6 hoursAt 18 months: Bayley MDI, blindness, deafness, CP
Vincer (1987)30BW <1500 g3 doses starting at 12 hoursAt 24 months: CP
Yaseen (1997)27BW <1750 1g3 doses starting at 12 hoursNo